Cardiac Surgery 2024 Reviewed

Abstract

For the 11th consecutive time, we systematically reviewed the cardio-surgical literature for the past year (2024), using the PRISMA approach for a results-oriented summary. In 2024, the discussion on the value of randomized and registry evidence increased, triggered by consistent findings in the field of coronary artery disease (CAD) and discrepant results in structural heart disease. The literature in 2024 again confirmed the excellent long-term outcomes of CABG compared with PCI in different scenarios, generating further validation for the CABG advantage reported in randomized studies. This has been reflected in the new guidelines for chronic CAD in 2024. Two studies indicate novel perspectives for CABG, showing that cardiac shockwave therapy in CABG improves myocardial function in ischemic hearts and that CABG guided by computed tomography is safe and feasible. For aortic stenosis, an early advantage for transcatheter (TAVI) compared with surgical (SAVR) treatment has found more support; however, long-term TAVI results keep being challenged, this year by new FDA and registry data in favor of SAVR. For failed aortic valves, redo-SAVR showed superior results compared with valve-in-valve TAVI. In the mitral field, studies showed short-term noninferiority for transcatheter treatment compared with surgery for secondary mitral regurgitation (MR), and significant long-term survival benefit in registries with surgery for primary MR. Finally, surgery was associated with better survival compared with medical therapy for acute type A aortic intramural hematoma. This article summarizes publications perceived as important by us. It cannot be complete nor free of individual interpretation but provides up-to-date information for patient-specific decision-making.

Keywords

coronary artery bypass graft surgery - CABG - aortic valve and root - mitral valve surgery - tricuspid valve

Publication History

Received: 27 January 2025

Accepted: 27 February 2025

Article published online:
27 March 2025

• References

• 1 Doenst T, Schneider U, Caldonazo T. et al. Cardiac Surgery 2022 Reviewed. Thorac Cardiovasc Surg 2023; 71 (05) 356-365
• 2 Kirov H, Caldonazo T, Mukharyamov M. et al. Cardiac surgery 2023 reviewed. Thorac Cardiovasc Surg 2024; 72 (05) 346-357
• 3 Caldonazo T, Fleckenstein P, Kirov H. et al. Herzklappenchirurgie–Literaturübersicht 202. Z Herz Thorax Gefasschir 2024; 38: 1-8
• 4 Kirov H, Caldonazo T, Diab M. et al. Koronarchirurgie – eine Literaturübersicht 2022. Z Herz Thorax Gefasschir 2023; 37: 231-236
• 5 Kirov H, Fleckenstein P, Caldonazo T. et al. Koronarchirurgie – eine Literaturübersicht 2023. Z Herz Thorax Gefasschir 2024; 38: 287-292
• 6 Simon P, Garfunkel A. The Boxer. In: Bridge over troubled water; Columbia Records; 1969
• 7 Irving M, Eramudugolla R, Cherbuin N, Anstey KJ. A critical review of grading systems: implications for public health policy. Eval Health Prof 2017; 40 (02) 244-262
• 8 Wang Y, Parpia S, Couban R. et al. Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors. J Clin Epidemiol 2024; 165: 111211
• 9 Greco A, Spagnolo M, Laudani C. et al. Assessment of noninferiority margins in cardiovascular medicine trials. JACC Adv 2024; 3 (07) 101021
• 10 Olivier CB, Struß L, Sünnen N. et al. Accuracy of event rate and effect size estimation in major cardiovascular trials: a systematic review. JAMA Netw Open 2024; 7 (04) e248818
• 11 Ronco D, Albuquerque AM, Marin-Cuartas M. et al; INTEGRITTY, and with the endorsement of the Latin American Association of Cardiac and Endovascular Surgery (LACES), the Latin European Alliance of Cardiovascular Surgical Societies (LEACSS), the Brazilian Society of Cardiovascular Surgery (BSCVS), the French Society of Thoracic and Cardio-Vascular Surgery (SFCTCV), the Italian Society for Cardiac Surgery (SICCH), the Mexican College of Cardiovascular and Thoracic Surgery, the Portuguese Society of Cardiac Thoracic and Vascular Surgery (SPCCTV) and the Spanish Cardiovascular and Endovascular Society (SECCE). Conflicts of interest in clinical practice: lessons learned from cardiovascular medicine. Eur J Cardiothorac Surg 2024; 66 (03) 66
• 12 Marin-Cuartas M. PARTNER-3-Studie als Begründung der „TAVI-First-Strategie “für alle Niedrig-Risiko-Patienten mit Aortenklappenstenose: Realität oder Zumutung?. Z Herz Thorax Gefasschir 2024; 38: 112-115
• 13 Barili F, Brophy JM, Ronco D. et al; International Evidence Grading Research Initiative Targeting Transparency and Quality (INTEGRITTY). Risk of bias in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: a systematic review and meta-analysis. JAMA Netw Open 2023; 6 (01) e2249321
• 14 Kahan BC, Rehal S, Cro S. Risk of selection bias in randomised trials. Trials 2015; 16: 405
• 15 Krauss A. Why all randomised controlled trials produce biased results. Ann Med 2018; 50 (04) 312-322
• 16 Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med 2017; 377 (05) 465-475
• 17 Bosdriesz JR, Stel VS, van Diepen M. et al. Evidence-based medicine-when observational studies are better than randomized controlled trials. Nephrology (Carlton) 2020; 25 (10) 737-743
• 18 Gitt AK, Bueno H, Danchin N. et al. The role of cardiac registries in evidence-based medicine. Eur Heart J 2010; 31 (05) 525-529
• 19 [Anonymous] Medical Devices regulations. . Accessed 2024 at: https://health.ec.europa.eu/medical-devices-sector/new-regulations_en
• 20 Fernainy P, Cohen AA, Murray E, Losina E, Lamontagne F, Sourial N. Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion. BMC Proc 2024; 18 (Suppl. 02) 1
• 21 Head SJ, Milojevic M, Daemen J. et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 2018; 391 (10124): 939-948
• 22 Serruys PW, Kageyama S, Pompilio G. et al. Coronary bypass surgery guided by computed tomography in a low-risk population. Eur Heart J 2024; 45 (20) 1804-1815
• 23 Doenst T, Teichgräber U. Fast-Track-CABG-Studie. Z Herz Thorax Gefasschir 2024; 38: 336-339
• 24 Holfeld J, Nägele F, Pölzl L. et al. Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. Eur Heart J 2024; 45 (29) 2634-2643
• 25 Boden WE, De Caterina R, Kaski JC. et al. Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines. Eur Heart J 2024; 45 (36) 3701-3706
• 26 Doenst T, Bonow RO, Bhatt DL, Falk V, Gaudino M. Improving terminology to describe coronary artery procedures: JACC review topic of the week. J Am Coll Cardiol 2021; 78 (02) 180-188
• 27 Brlecic PE, Hogan KJ, Treffalls JA. et al. Safety of early discharge after coronary artery bypass grafting: a nationwide readmissions analysis. Ann Thorac Surg 2024; 118 (03) 701-710
• 28 Urso S, Sadaba R, González-Martín JM. et al. Coronary surgery provides better survival than drug-eluting stent: A pooled meta-analysis of Kaplan-Meier-derived individual patient data. J Thorac Cardiovasc Surg 2024; 167 (06) 2138-2146.e3
• 29 Omerovic E, Ramunddal T, Petursson P. et al. Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry. Eur Heart J 2025; 46 (06) 518-531
• 30 Kirov H, Fischer J, Caldonazo T. et al. Coronary artery bypass grafting versus percutaneous coronary intervention in patients with chronic total occlusion. Thorac Cardiovasc Surg 2024;
• 31 Bloom JE, Vogrin S, Reid CM. et al. Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival. Eur Heart J 2025; 46 (01) 72-80
• 32 Gaba P, Christiansen EH, Nielsen PH. et al. Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials. JAMA Cardiol 2023; 8 (07) 631-639
• 33 Kirov H, Caldonazo T, Khayyat AD. et al. Comparing percutaneous coronary intervention and coronary artery bypass grafting for left main stenosis on the basis of current regional registry evidence. JTCVS Open 2024; 22: 257-271
• 34 Byrne RA, Fremes S, Capodanno D. et al. 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. Eur J Cardiothorac Surg 2023; 64 (02) 64
• 35 Dimagli A, Spadaccio C, Myers A. et al. Quality of life after percutaneous coronary intervention versus coronary artery bypass grafting. J Am Heart Assoc 2023; 12 (22) e030069
• 36 Doenst T, Haverich A, Serruys P. et al. PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J Am Coll Cardiol 2019; 73 (08) 964-976
• 37 Gaudino M, Audisio K, Hueb WA. et al. Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: an individual patient data pooled meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2024; 167 (03) 1022-1032.e14
• 38 Kirov H, Caldonazo T, Toshmatov S. et al. Long-term survival in elderly patients after coronary artery bypass grafting compared to the age-matched general population: a meta-analysis of reconstructed time-to-event data. Thorac Cardiovasc Surg 2024;
• 39 Park SJ, Ahn JM, Kang DY. et al; PREVENT Investigators. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet 2024; 403 (10438): 1753-1765
• 40 Vrints C, Andreotti F, Koskinas KC. et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 2024; 45 (36) 3415-3537
• 41 Doenst T, Borger M, Falk V, Milojevic M. ESC/EACTS guideline for chronic coronary syndrome-invasive treatment perspectives important for daily practice. Eur J Cardiothorac Surg 2024; 66 (04) 66
• 42 Richter M, Moschovas A, Bargenda S. et al. Off-pump reduces risk of coronary bypass grafting in patients with high MELD-XI score. Thorac Cardiovasc Surg 2024;
• 43 Sabik III JF, Mehaffey JH, Badhwar V. et al. Multiarterial vs single-arterial coronary surgery: 10-year follow-up of 1 million patients. Ann Thorac Surg 2024; 117 (04) 780-788
• 44 Jameie M, Valinejad K, Pashang M. et al. Impact of multiarterial revascularization on long-term major adverse cardiovascular events after coronary bypass in 23,798 patients. Ann Thorac Surg 2024; 118 (04) 863-872
• 45 Ren J, Bowyer A, Tian DH, Royse C, El-Ansary D, Royse A. Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes. Eur Heart J 2024; 45 (28) 2536-2544
• 46 Doenst T, Faerber G. Challenge-skill balance in cardiac surgery: an attempt to explain sex-related differences in coronary surgery. Eur Heart J 2024; 45 (28) 2545-2547
• 47 Shimamura J, Miyamoto Y, Hibino M. et al. Long-term outcomes after hybrid coronary revascularization versus coronary artery bypass grafting: meta-analysis of kaplan-meier-derived data. Am J Cardiol 2024; 212: 13-22
• 48 Sandner S, Antoniades C, Caliskan E. et al. Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoracic Surgery Coronary Task Force. Eur J Cardiothorac Surg 2024; 66 (06) 66
• 49 Guo MH, Toubar O, Issa H. et al. Long-term survival, cardiovascular, and functional outcomes after minimally invasive coronary artery bypass grafting in 566 patients. J Thorac Cardiovasc Surg 2024; 168 (04) 1080-1088.e2
• 50 Claessens J, Packlé L, Oosterbos H. et al. Totally endoscopic coronary artery bypass grafting: experience in 1500 patients. Interdiscip Cardiovasc Thorac Surg 2024; 39 (03) 39
• 51 Nisivaco S, Kitahara H, Bhasin R, Patel B, Coleman C, Balkhy HH. A decade of robotic beating-heart totally endoscopic coronary bypass (TECAB) at a single institution: outcomes with 10-year follow-up. J Thorac Cardiovasc Surg 2024; S0022-5223 (24)00682-2
• 52 Babliak O, Lazoryshynets V, Demianenko V. et al. New approach to the mitral valve through the left anterior minithoracotomy for combined valve and coronary surgical procedures. JTCVS Tech 2023; 24: 57-63
• 53 Babliak O, Demianenko V, Babliak D, Marchenko A, Melnyk Y, Stohov O. New approach for combined aortic valve and coronary procedures through the left anterior minithoracotomy. Interdiscip Cardiovasc Thorac Surg 2024; 38 (01) 38
• 54 Lee Y, Im S, Kang Y, Sohn SH, Jang MJ, Hwang HY. Impact of perioperative high-intensity statin treatment on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting: a meta-analysis. Acute Crit Care 2024; 39 (04) 507-516
• 55 Kirov H, Caldonazo T, Runkel A. et al. Colchicine in patients with coronary disease who underwent coronary artery bypass surgery: a meta-analysis of randomized controlled trials. Am J Cardiol 2024; 231: 48-54
• 56 Yu M, Yang Y, Dong SL. et al. Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial. Circulation 2024; 150 (13) 981-993
• 57 Zhu Y, Zhang W, Dimagli A. et al. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. BMJ 2024; 385: e075707
• 58 Choi K, Schaff HV, Villavicencio MA. et al. Effect of preoperative clopidogrel on outcomes of isolated coronary artery bypass graft: an STS National Database Analysis. Ann Thorac Surg 2024; 118 (05) 1054-1062
• 59 Blankenberg S, Seiffert M, Vonthein R. et al; DEDICATE-DZHK6 Trial Investigators. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med 2024; 390 (17) 1572-1583
• 60 Narayan P. DEDICATE trial: the devil lies in the definition of “low risk”. Indian J Thorac Cardiovasc Surg 2024; 40 (04) 507-510
• 61 Beyersdorf F, Bauer T, Freemantle N. et al; GARY Executive Board. Five-year outcome in 18,010 patients from the German Aortic Valve Registry. Eur J Cardiothorac Surg 2021; 60 (05) 1139-1146
• 62 Thyregod HGH, Jørgensen TH, Ihlemann N. et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 2024; 45 (13) 1116-1124
• 63 Urso S, Sadaba R, Nogales E, Portela F. Why does the NOTION trial show poorer than expected outcomes in the surgical arm?. Hearts (Basel) 2022; 3: 14-18
• 64 Krasniqi L, Brandes A, Mortensen PE, Gerke O, Riber L. Severe aortic stenosis treated with transcatheter aortic valve implantation or surgical aortic valve replacement with Perimount in Western Denmark 2016-2022: a nationwide retrospective study. Interdiscip Cardiovasc Thorac Surg 2024; 39 (01) 39
• 65 Mack MJ, Leon MB, Thourani VH. et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med 2023; 389 (21) 1949-1960
• 66 Administration USFaD. In, Post-Approval Studies (PAS) Database. FDA. Accessed 2024 at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_pas.cfm?t_id=664035&c_id=5611
• 67 Lønborg J, Jabbari R, Sabbah M. et al; NOTION-3 Study Group. PCI in patients undergoing transcatheter aortic-valve implantation. N Engl J Med 2024; 391 (23) 2189-2200
• 68 Kedhi E, Hermanides RS, Dambrink JE. et al; TCW study group. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial. Lancet 2025; 404 (10471): 2593-2602
• 69 Rodés-Cabau J, Ribeiro HB, Mohammadi S. et al; VIVA (Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli) Trial Investigators. Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis and small aortic annulus: a randomized clinical trial. Circulation 2024; 149 (09) 644-655
• 70 365 E. SAVR and TAVI comparison across the Globe based on current regional registry evidence - a meta-analysis of reconstructed time-to-event data. . Accessed 2024 at: https://esc365.escardio.org/presentation/290419
• 71 Auer J, Krotka P, Reichardt B. et al. Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study. Eur J Cardiothorac Surg 2024; 66 (01) 66
• 72 Mehaffey JH, Jagadeesan V, Kawsara M. et al. Transcatheter vs surgical aortic valve replacement in bicuspid aortic valves. Ann Thorac Surg 2024:S0003-4975(24)01044-0
• 73 Sá MP, Sun T, Fatehi Hassanabad A. et al. Complete transcatheter versus complete surgical treatment in patients with aortic valve stenosis and concomitant coronary artery disease: study-level meta-analysis with reconstructed time-to-event data. J Card Surg 2022; 37 (07) 2072-2083
• 74 Biancari F, D'Errigo P, Barbanti M. et al. Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: the OBSERVANT study. Int J Cardiol Heart Vasc 2024; 55: 101545
• 75 Andrade C. Poorly recognized and uncommonly acknowledged limitations of randomized controlled trials. Indian J Psychol Med 2025; 47 (01) 83-85
• 76 Biancari F, Mäkikallio T, D'Errigo P, Polvani G. Value of observational studies in the outcome evaluation of transcatheter and surgical aortic valve replacement. Interdiscip Cardiovasc Thorac Surg 2024; 39 (06) 39
• 77 Bekeredjian R, Szabo G, Balaban Ü. et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J 2019; 40 (17) 1323-1330
• 78 Thourani VH, Habib R, Szeto WY. et al. Survival after surgical aortic valve replacement in low-risk patients: a contemporary trial benchmark. Ann Thorac Surg 2024; 117 (01) 106-112
• 79 Arnold SV, Manandhar P, Vemulapalli S. et al. Trends in transcatheter aortic valve replacement outcomes: insights from the STS/ACC TVT registry. JAMA Cardiol 2024; 9 (12) 1115-1123
• 80 Généreux P, Schwartz A, Oldemeyer JB. et al; EARLY TAVR Trial Investigators. Transcatheter aortic-valve replacement for asymptomatic severe aortic stenosis. N Engl J Med 2025; 392 (03) 217-227
• 81 Javadikasgari H, McGurk S, Newell PC, Awtry JA, Sabe AA, Kaneko T. Evolving concept of aortic valve replacement in asymptomatic patients with severe aortic stenosis. Ann Thorac Surg 2024; 117 (04) 796-803
• 82 Vahl TP, Thourani VH, Makkar RR. et al. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study. Lancet 2024; 403 (10435): 1451-1459
• 83 Herrmann HC, Mehran R, Blackman DJ. et al; SMART Trial Investigators. Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus. N Engl J Med 2024; 390 (21) 1959-1971
• 84 Scotti A, Sturla M, Costa G. et al. Evolut PRO and SAPIEN ULTRA performance in small aortic annuli: the OPERA-TAVI registry. JACC Cardiovasc Interv 2024; 17 (05) 681-692
• 85 Stolte T, Boeddinghaus J, Allegra G. et al. Incidence and outcomes of valve-in-valve transcatheter aortic valve implantation in failed bioprosthetic valves. J Clin Med 2023; 12 (18) 12
• 86 Tran JH, Itagaki S, Zeng Q. et al. Transcatheter or surgical replacement for failed bioprosthetic aortic valves. JAMA Cardiol 2024; 9 (07) 631-639
• 87 Sá MP, Jacquemyn X, Serna-Gallegos D. et al. Long-term outcomes of valve-in-valve transcatheter aortic valve implantation versus redo surgical aortic valve replacement: meta-analysis of kaplan-meier-derived data. Am J Cardiol 2024; 212: 30-39
• 88 Yang B, Ghita C, Makkinejad A, Green C, Wu X. Early outcomes of the Y-incision technique to enlarge the aortic annulus 3 to 4 valve sizes. J Thorac Cardiovasc Surg 2024; 167 (04) 1196-1205.e2
• 89 Horke A, Tudorache I, Laufer G. et al. Five-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement-the ARISE Study and ARISE Registry Data. Eur J Cardiothorac Surg 2024; 65 (04) 65
• 90 Sá MP, Jacquemyn X, Awad AK. et al. Valve-sparing aortic root replacement with reimplantation vs remodeling: a meta-analysis. Ann Thorac Surg 2024; 117 (03) 501-507
• 91 Oo AY, Loubani M, Gerdisch MW. et al. On-X aortic valve replacement patients treated with low-dose warfarin and low-dose aspirin. Eur J Cardiothorac Surg 2024; 65 (05) 65
• 92 Anker SD, Friede T, von Bardeleben RS. et al; RESHAPE-HF2 Investigators. Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation. N Engl J Med 2024; 391 (19) 1799-1809
• 93 Baldus S, Doenst T, Pfister R. et al; MATTERHORN Investigators. Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N Engl J Med 2024; 391 (19) 1787-1798
• 94 Doenst T, Caldonazo T, Mukharyamov M, Tasoudis P, Kirov H. Survival correlates with regurgitation degree before and after invasive atrioventricular valve treatment. Thorac Cardiovasc Surg 2024;
• 95 Chikwe J, Chen Q, Bowdish ME. et al. Surgery and transcatheter intervention for degenerative mitral regurgitation in the United States. J Thorac Cardiovasc Surg 2025; 169 (01) 80-88.e19
• 96 Hussain S, Swystun AG, Caputo M, Angelini GD, Vohra HA. A review and meta-analysis of conventional sternotomy versus minimally invasive mitral valve surgery for degenerative mitral valve disease focused on the last decade of evidence. Perfusion 2024; 39 (05) 988-997
• 97 Hanafy DA, Melisa S, Andrianto GA, Suwatri WT. Sugisman. Outcomes of minimally invasive versus conventional sternotomy for redo mitral valve surgery according to Mitral Valve Academic Research Consortium: a systematic review and meta-analysis. Asian J Surg 2024; 47 (01) 35-42
• 98 Akowuah EF, Maier RH, Hancock HC. et al; UK Mini Mitral Trial Investigators. Minithoracotomy vs conventional sternotomy for mitral valve repair: a randomized clinical trial. JAMA 2023; 329 (22) 1957-1966
• 99 Jeppsson A, Rocca B, Hansson EC. et al; Authors/Task Force Members, (Co-Chairperson) (Sweden), (Co-Chairperson) (Italy); (Sweden); (Iceland); (Sweden); (United Kingdom); (Germany); (Italy); (Portugal); (Finland); (Denmark); (Austria); (Spain); (Portugal); (Serbia), EACTS Scientific Document Group. 2024 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg 2024; 67 (01) ezae355
• 100 Hahn RT, Makkar R, Thourani VH. et al; TRISCEND II Trial Investigators. Transcatheter valve replacement in severe tricuspid regurgitation. N Engl J Med 2025; 392 (02) 115-126
• 101 Ahn JH, Yang JH, Song YB. et al. Impact of chronic total coronary occlusion location on long-term survival after percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed) 2019; 72 (09) 717-723
• 102 Nickenig G, Lurz P, Sorajja P. et al; TRILUMINATE Investigators. Percutaneous edge-to-edge repair for tricuspid regurgitation: 3-year outcomes from the TRILUMINATE Study. JACC Cardiovasc Interv 2024; 17 (18) 2113-2122
• 103 Dreyfus J, Juarez-Casso F, Sala A. et al. Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE. Eur Heart J 2024; 45 (42) 4512-4522
• 104 Dreyfus J, Galloo X, Taramasso M. et al; TRIGISTRY investigators. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart J 2024; 45 (08) 586-597
• 105 Shah P, Looby M, Dimond M. et al. Evaluation of the hemocompatibility of the direct oral anticoagulant apixaban in left ventricular assist devices: the DOAC LVAD study. JACC Heart Fail 2024; 12 (09) 1540-1549
• 106 Lauenroth V, Zittermann A, Lucke S, Gummert JF, Morshuis M. Driveline infection according to driveline positioning in left ventricular assist device implant recipients. Int J Artif Organs 2024; 47 (02) 118-121
• 107 Rega F, Lebreton G, Para M. et al; NIHP2019 investigators. Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial. Lancet 2024; 404 (10453): 670-682
• 108 Nemeth E, Soltesz A, Kovacs E. et al. Use of intraoperative haemoadsorption in patients undergoing heart transplantation: a proof-of-concept randomized trial. ESC Heart Fail 2024; 11 (02) 772-782
• 109 Emerson D, Catarino P, Rampolla R, Chikwe J, Megna D. Robotic-assisted lung transplantation: first in man. J Heart Lung Transplant 2024; 43 (01) 158-161
• 110 Czerny M, Grabenwöger M, Berger T. et al; Authors/Task Force Members, EACTS/STS Scientific Document Group. EACTS/STS guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. Ann Thorac Surg 2024; 118 (01) 5-115
• 111 Hage F, Atarere J, Anteby R. et al. Total arch vs hemiarch repair in acute type a aortic dissection: systematic review and meta-analysis of comparative studies. CJC Open 2024; 6 (09) 1075-1086
• 112 Sá MP, Tasoudis P, Jacquemyn X. et al. Late outcomes of surgery versus medical therapy in patients with type a aortic intramural hematoma: meta-analysis of reconstructed time-to-event data. Am J Cardiol 2024; 210: 1-7
• 113 Sá MP, Jacquemyn X, Hess N. et al. Extracorporeal life support after surgical repair for acute type a aortic dissection: a systematic review and meta-analysis. Perfusion 2024; 26 76591241253464